253 related articles for article (PubMed ID: 31225916)
1. Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.
Straub JO; Oldenkamp R; Pfister T; Häner A
Environ Toxicol Chem; 2019 Oct; 38(10):2259-2278. PubMed ID: 31225916
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
Liebig M; Moltmann JF; Knacker T
Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
[TBL] [Abstract][Full Text] [Related]
3. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
Straub JO
Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
[TBL] [Abstract][Full Text] [Related]
4. Combined environmental risk assessment for the antiviral pharmaceuticals ganciclovir and valganciclovir in Europe.
Straub JO
Environ Toxicol Chem; 2017 Aug; 36(8):2205-2216. PubMed ID: 28198039
[TBL] [Abstract][Full Text] [Related]
5. Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations.
Caldwell DJ; D'Aco V; Davidson T; Kappler K; Murray-Smith RJ; Owen SF; Robinson PF; Simon-Hettich B; Straub JO; Tell J
Chemosphere; 2019 Feb; 216():855-865. PubMed ID: 30385066
[TBL] [Abstract][Full Text] [Related]
6. Environmental risk assessment for ancillary substances in biotechnological production of pharmaceuticals.
Straub JO; Gysel D; Kastl U; Klemmer J; Sonderegger M; Studer M
Environ Toxicol Chem; 2012 Mar; 31(3):681-7. PubMed ID: 22189954
[TBL] [Abstract][Full Text] [Related]
7. Consideration of exposure and species sensitivity of triclosan in the freshwater environment.
Capdevielle M; Van Egmond R; Whelan M; Versteeg D; Hofmann-Kamensky M; Inauen J; Cunningham V; Woltering D
Integr Environ Assess Manag; 2008 Jan; 4(1):15-23. PubMed ID: 18260205
[TBL] [Abstract][Full Text] [Related]
8. Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe.
Straub JO
Environ Toxicol Chem; 2016 Apr; 35(4):767-79. PubMed ID: 25693841
[TBL] [Abstract][Full Text] [Related]
9. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
Jones OA; Voulvoulis N; Lester JN
Water Res; 2002 Dec; 36(20):5013-22. PubMed ID: 12448549
[TBL] [Abstract][Full Text] [Related]
10. Use of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals.
Vestel J; Caldwell DJ; Constantine L; D'Aco VJ; Davidson T; Dolan DG; Millard SP; Murray-Smith R; Parke NJ; Ryan JJ; Straub JO; Wilson P
Environ Toxicol Chem; 2016 May; 35(5):1201-12. PubMed ID: 26403382
[TBL] [Abstract][Full Text] [Related]
11. Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe.
Straub JO
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():540-66. PubMed ID: 19958049
[TBL] [Abstract][Full Text] [Related]
12. Country-Specific Environmental Risks of Fragrance Encapsulates Used in Laundry Care Products.
Cai Y; Lin J; Gimeno S; Begnaud F; Nowack B
Environ Toxicol Chem; 2022 Apr; 41(4):905-916. PubMed ID: 34265099
[TBL] [Abstract][Full Text] [Related]
13. Rational selection of alternative, environmentally compatible surfactants for biotechnological production of pharmaceuticals--a step toward green biotechnology.
Straub JO; Shearer R; Studer M
Environ Toxicol Chem; 2014 Sep; 33(9):2140-6. PubMed ID: 24917475
[TBL] [Abstract][Full Text] [Related]
14. A critical evaluation of different parameters for estimating pharmaceutical exposure seeking an improved environmental risk assessment.
Pereira AMPT; Silva LJG; Lino CM; Meisel LM; Pena A
Sci Total Environ; 2017 Dec; 603-604():226-236. PubMed ID: 28628814
[TBL] [Abstract][Full Text] [Related]
15. An Environmental Risk Assessment for Human-Use Trimethoprim in European Surface Waters.
Straub JO
Antibiotics (Basel); 2013 Mar; 2(1):115-62. PubMed ID: 27029296
[TBL] [Abstract][Full Text] [Related]
16. Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER.
Schowanek D; Webb S
Toxicol Lett; 2002 May; 131(1-2):39-50. PubMed ID: 11988357
[TBL] [Abstract][Full Text] [Related]
17. Environmental hazard and risk assessment of thiochemicals. Application of integrated testing and intelligent assessment strategies (ITS) to fulfil the REACH requirements for aquatic toxicity.
Ahlers J; Nendza M; Schwartz D
Chemosphere; 2019 Jan; 214():480-490. PubMed ID: 30278402
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment of triclosan released from sewage treatment plants in European rivers using a combination of risk quotient methodology and Monte Carlo simulation.
Thomaidi VS; Matsoukas C; Stasinakis AS
Sci Total Environ; 2017 Dec; 603-604():487-494. PubMed ID: 28641188
[TBL] [Abstract][Full Text] [Related]
19. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
Straub JO
Toxicol Lett; 2002 Oct; 135(3):231-7. PubMed ID: 12270681
[TBL] [Abstract][Full Text] [Related]
20. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
Straub JO
Toxicol Lett; 2002 May; 131(1-2):137-43. PubMed ID: 11988366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
